MSM 2003HIV positive 17 % 2005HIV positive 28 % 2007HIV positive 32 %

Slides:



Advertisements
Similar presentations
PrEP: HIV Pre-exposure Prophylaxis Katherine Marx, MS, MPH, FNP-BC June 2014.
Advertisements

Dr. Carol Odula (Obs./Gyn.) May 7 th 2013 Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection.
What is it? How may it help women? PrEP. What is PrEP? How would it work? What do we know about it? When will we know more? What could it mean for women?
Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
UN Cares PEP Starter Kit Custodians Training MODULE 4: HIV Post-Exposure Prophylaxis Starter Kits.
Maurice Cook ( EM Designs Group, Inc.) The End of AIDS Transmission? Robert M Grant, June 2012.
Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection James Wilton Project Coordinator Biomedical Science of HIV Prevention
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
Hadiyah Charles, Community HIV/AIDS Mobilization Project Naina Khanna, WORLD/U.S. Positive Women’s Network HIV Research Catalyst Forum April 21, 2010.
HIV Prophylaxis: Following Occupational and Non-Occupational Exposure Nanik (Nayri) Hatsakorzian Pharm.D./MPH candidate 2014 Touro University, College.
Potential role of PEP, PrEP and ART for HIV Prevention among Men who have Sex with Men Frits van Griensven, PhD, MPH Division of HIV/AIDS Prevention US.
The Global Response to AIDS: Does It Pass the Test for Women? Peter Piot Institute for Global Health Imperial College.
Epidemiology of HIV and Access to Prevention services, Tanzania Joint Biennial HIV National Response Review Stakeholders meeting. November, 2014 Blue Pearl.
New York State Department of Health AIDS Institute June, 2014
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
The potential and challenges of ARV-based HIV prevention: An overview
Can we prevent infection after an exposure
HIV/AIDS Chapter 21 Human Immunodeficiency Virus (HIV) Acquired immune Deficiency Syndrome (AIDS) (Pg 496)
Hepatitis C Education & Awareness. Women In Government Women In Government Foundation, Inc. is a national, non-profit, non-partisan organization of women.
Introduction to HIV New Prevention Technologies (NPTs)
HIV/STD Presentation Jace Dyckman Prevention Health Specialist
N ORTHWEST AIDS E DUCATION AND T RAINING C ENTER PrEP 201: Beyond the Basics Joanne Stekler, MD MPH Associate Professor of Medicine University of Washington.
Cindra Feuer and Marc-André LeBlanc HRCF, 21 April 2010 ARV-based Prevention.
The Strategic Use of ARVs | IAC Satellite, July 22, |1 | Strategic Use of Antiretroviral Drugs WHO Perspective for Future Guidelines Chair of WHO.
Willingness to use HIV prevention strategies to conceive with an HIV-positive partner: opinions from HIV-negative women in serodifferent relationships.
ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES XVIII International AIDS Conference, July , Vienna Austria Recent Trends in estimated HIV-1.
HIV CARE UNDER THE AFFORDABLE CARE ACT: ADAP’S IN THE NEW ERA Richard Aleshire, MSW Program Manager, HIV Client Services Office of Infectious Disease Washington.
Alliance Discussion with Office of AIDS: November HIV/AIDS Surveillance Surveillance overview HIV Incidence Surveillance Second Surveillance Stakeholder.
National Working Group on Microbicides The Basics of Microbicides Amitrajit Saha PATH January 2007.
HIV and AIDS By Lindsey Wilderotter. What is HIV/AIDS? HIV is a virus and therefore the pathogen that attacks the immune system and also known as a retrovirus.
HIV post exposure prophylaxis on your medical elective Dr Sarah Barrett Consultant Sexual Health and HIV Medicine Birmingham Heartlands Hospital.
Michael Hughes, MD Assistant Clinical Professor UCR Eisenhower Medical Associates.
HIV and AIDS By Lindsey Wilderotter. What is HIV/AIDS? HIV is a virus and therefore the pathogen that attacks the immune system and also known as a retrovirus.
IMPORTANT DEVELOPMENTS IN THE HISTORY OF AIDS A Timeline of AIDS.
SHAPE BINGO
School: Shrimati Indira Gandhi SSS, Mauritius Age group: Form 4, yrs Subject: Art and Design.
Sexually Transmitted Infections Mr. Springer 8 th Grade Health.
PrEP Update: The science, new tools, and next steps Dawn K. Smith MD, MS, MPH Division of HIV/AIDS Prevention, CDC “The findings and conclusions in this.
N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER Pre-exposure Prophylaxis for HIV Prevention Efficacy and the importance of adherence Joanne Stekler,
Allie Lyman.  Incidence and Prevalence  Risk Factors and Barriers to Prevention  Prevention  Conclusion.
HIV post exposure prophylaxis on your medical elective Dr Ria Daly Specialist Trainee GUM/HIV Birmingham Heartlands Hospital (Dr Sarah Barrett)
A pill to prevent HIV? For women??
New Prevention Technologies Workshop Module 2: NPTs in context
HIV and Pregnancy. Introduction In the general obstetrical population in the United States, the frequency of HIV infection is about 1 per The prevalence.
Hepatitis B Neha Patel, Rebecca Webber, Lilimae Martin.
HIV Prevalence and Incidence Estimates Among Women with High Risk Indicators in Addis Ababa, Ethiopia Asfawesen G-Yohanes 1, Stephanie Combes 2, Abraham.
CHAIN OF INFECTION STI POINT OF VIEW.
HIV Prevention: A Winnable Battle Centers for Disease Control and Prevention.
HIV and Women Collaborating Across Borders to Advance the Health of Women IAS 2012 Gina M. Brown, M.D. July 22, 2012.
The tipping point: When do placebos become unethical? Bridget Haire.
BRADFORD BRIGGS & NIKE JACKSON. BRADFORD BRIGGS Prevention Toolbox.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Thailand Last updated: January 2016.
Pre-exposure Prophylaxis (PrEP) for HIV Prevention: What’s the Future? Joanne Stekler, MD MPH Assistant Professor of Medicine University of Washington.
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
PrEP for HIV Prevention
HIV Burden Among Gay and Bisexual Men in the U.S.
A protocol in development IMPAACT Prevention Scientific Committee
PrEP as an HIV Prevention Tool in Queer Communities of Color: Barriers and Opportunities BACKGROUND Joanne Stekler, MD MPH.
Tenvir-Em Tenvir EM is a generic version of Truvada and is used as part of a regiment of antiretroviral medications to treat HIV-1 in adults over 18. Each.
On Demand PrEP for Men at High Risk for HIV IPERGAY
HIV: Effects on the Human Body, Transmission Myths and Facts
Managing Women Living With HIV Infection
PrEP Effectiveness. Preexposure Prophylaxis Translating the Clinical Trials Into Clinical Practice.
Stopping the Epidemic HIV Prevention Today
Pre-Exposure Prophylaxis (PrEP) for HIV Infection
PrEP Pre-Exposure Prophylaxis
Initiating Pre-exposure Prophylaxis The PrEP Checklist
Distribution of HIV incidence by mode of exposure in Peru:
HIV in Minnesota: Challenges and Opportunities
Bob Holtkamp, Director of Prevention & Outreach
Presentation transcript:

MSM 2003HIV positive 17 % 2005HIV positive 28 % 2007HIV positive 32 %

HIV prevalence among MSW Bangkok, Chiang Mai and Phuket, 2005–2007

Percent Seroprevalence Year Sources: Army Institute of Pathology Armed Forces Research Institute of Medical Sciences, RTA HIV-1 Seroprevalence of Royal Thai Army Conscripts,

HIV-1 Incidence among RTA Conscripts from 2005 – 2009 YearNo ConscriptsNo anti-HIV-1 positives Prevalence (%) No Samples for BED CEIA (%) Estimated Incidence 2005 (Nov)29, (99.3) , (96.0) , (99.3) , (96.7) , (93.4)0.25 Sources: Armed Forces Research Institute of Medical Sciences, RTA

HIV Incidences at Time of Entry into Royal Thai Army, Sources: Armed Forces Research Institute of Medical Sciences, RTA

Median HIV Prevalence and BED Adjusted Incidence among ANC Pregnant Women in Sentinel Provinces Median prevalence (% per year) BED adjusted incidence (% per year)

Median HIV Prevalence and BED Adjusted Incidence among Direct Sex Workers Median prevalence (% per year) BED adjusted incidence (% per year)

Median HIV Prevalence and BED Adjusted Incidence among indirect Sex Workers Median prevalence (% per year) BED adjusted incidence (% per year)

BED-CEIA Results Group risk %Recent case of HIV in BED Project ANC DCSW ICSW Total

BED-CEIA Results (cont.)

11 Improving HIV prevention 1.Do better with the strategies that we already have 2.Develop new biomedical technologies to prevent HIV 3.Adopt a more comprehensive approach to HIV prevention

July 3, 2012 FDA approved home HIV test

13 Turning to antiretrovirals for prevention The use of antiretrovirals for prevention by… 1.HIV-positive individuals to reduce their risk of transmitting HIV –Treatment as prevention 2.HIV-negative individuals to reduce their risk of infection –Post-exposure prophylaxis (PEP) –Pre-exposure prophylaxis (PrEP)

What is pre-exposure prophylaxis (PrEP)? Pre  Before (and after) Exposure  When a fluid containing HIV comes into contact with mucous membranes or non-intact skin Prophylaxis  An action taken to prevent infection or disease 14

15 How does PrEP work? Infection does not occur instantly after an exposure to HIV The virus needs to spread throughout the body This may take up to 3 days after the exposure The “window of opportunity” for PrEP The brief period of time - after an exposure - where HIV has not yet spread throughout the body During this time, PrEP may be able to stop HIV from causing an infection

16 What does the research say about PrEP? iPrExTDF2Partners PrEP Men who have sex with men (MSM) and trans women Heterosexual men and womenSerodiscordant heterosexual couples Daily Truvada pill Daily Viread pill Daily Truvada pill 44%63%62% (Viread) 73% (Truvada) 73%78%- Nausea Headache Decrease in kidney function and bone density Drug resistance Nausea Vomiting Dizziness Nausea Diarrhea